Stocks To Buy Monday, August 5, 2013 11:18:25 PM Sym - Name

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Stocks To Buy Monday, August 5, 2013 11:18:25 PM
Sym - Name - Last - Change  - Today's Opinion - Previous Opinion - Last Week's Opinion - Last Month's Opinion
SHOO Steven Madden 55.27 +1.96 100% Buy 100% Buy 96% Buy 100% Buy
CTHR Charles & Colvard Ltd 6.04 +0.63 100% Buy 100% Buy 88% Buy Hold
ACTV Active Network Inc 11.30 +0.97 100% Buy 100% Buy 56% Buy 96% Buy
SWHC Smith & Wesson Holding Cor 13.23 +0.78 100% Buy 100% Buy 72% Buy 96% Buy
DATE Jiayuan.Com International 8.69 +1.85 100% Buy 100% Buy 88% Buy 32% Buy
NAVR Navarre Corp. 3.63 +0.12 100% Buy 100% Buy 100% Buy 72% Buy
WPO Washington Post Company 568.70 +8.75 100% Buy 100% Buy 96% Buy 96% Buy
PRFT Perficient 16.90 +0.87 100% Buy 100% Buy 32% Buy 100% Buy
SAM Boston Beer Company 213.24 +8.82 100% Buy 100% Buy 80% Buy 96% Buy
CATM Cardtronics 34.58 +1.30 100% Buy 100% Buy 64% Buy 48% Buy
MYL Mylan Inc. 36.88 +0.48 100% Buy 100% Buy 96% Buy 16% Buy
MXL Maxlinear Inc 8.02 +0.01 100% Buy 100% Buy 40% Buy 100% Buy
TSN Tyson Foods 29.69 +1.18 100% Buy 100% Buy 64% Buy 100% Buy
LYG Lloyds Banking Group Plc 4.68 +0.17 100% Buy 100% Buy 88% Buy 88% Buy
FISV Fiserv 100.35 +2.17 100% Buy 100% Buy 88% Buy 56% Buy
TKMR Tekmira Pharmaceuticals 5.91 +0.12 100% Buy 100% Buy 72% Buy 72% Buy
CRVL Corvel 36.26 +1.02 100% Buy 100% Buy 8% Buy 96% Buy
INO Inovio Pharmaceuticals 3.00 +0.92 100% Buy 100% Buy 96% Buy 96% Buy
EVOL Evolving Systems 7.75 +0.41 100% Buy 100% Buy 64% Buy 80% Buy
SSH Sunshine Heart Inc 8.82 +1.32 100% Buy 72% Buy 88% Buy 8% Buy
ULTI The Ultimate Software Grou 147.35 +2.09 100% Buy 100% Buy 88% Buy 100% Buy
LAD Lithia Motors 67.26 +1.32 100% Buy 100% Buy 96% Buy 96% Buy
SPSC Sps Commerce 70.52 +0.91 100% Buy 100% Buy 100% Buy 100% Buy
PPO Polypore International Inc 45.50 +1.47 100% Buy 100% Buy 16% Buy 56% Buy
Z Zillow Inc. Cl A 90.05 +3.34 100% Buy 100% Buy 96% Buy 24% Buy
COWN Cowen Group 3.58 +0.37 100% Buy 32% Buy 96% Buy 8% Buy
WST West Pharmaceutical Servic 78.49 +2.19 100% Buy 88% Buy 16% Buy 100% Buy
ANIK Anika Therapeutics Inc. 26.77 -0.51 100% Buy 100% Buy 72% Buy 96% Buy
LEDR Market Leader Inc 13.05 +0.24 100% Buy 100% Buy 96% Buy 96% Buy
OMCL Omnicell 22.95 +0.01 100% Buy 100% Buy 72% Buy 72% Buy
ZLTQ Zeltiq Aesthetics Inc. 8.71 +0.47 100% Buy 100% Buy 48% Buy 80% Buy
RTN Raytheon Company 76.08 +0.43 100% Buy 100% Buy 96% Buy 8% Buy
HEI.A Heico Cp Cl A 41.70 +0.93 100% Buy 96% Buy 96% Buy 40% Buy
DXYN The Dixie Group 10.50 +0.63 100% Buy 100% Buy 8% Sell 80% Buy
FCVA First Capital Bancorp Inc 3.85 +0.12 100% Buy 88% Buy 96% Buy 72% Buy
PNR Pentair 63.21 +0.68 100% Buy 100% Buy 64% Buy 64% Buy
DL China Distance Education 11.16 +1.20 100% Buy 100% Buy 96% Buy 88% Buy
DRQ Dril-Quip 102.66 +1.65 100% Buy 100% Buy 16% Sell 96% Buy
VPRT Vistaprint N.V. 55.72 +0.71 100% Buy 100% Buy 72% Buy 88% Buy
CIR Circor International 58.70 +0.42 100% Buy 100% Buy 8% Buy 88% Buy
EGN Energen Corp. 66.43 +1.02 100% Buy 100% Buy 56% Buy 80% Buy
NQ Netqin Mobile Inc. 17.95 +2.04 100% Buy 96% Buy 100% Buy 56% Buy
NOC Northrop Grumman Corp. 95.42 +0.53 100% Buy 100% Buy 96% Buy 80% Buy
PGTI Pgt 11.45 -0.03 100% Buy 100% Buy 64% Buy 96% Buy
AXE Anixter International Inc. 86.19 +0.32 100% Buy 100% Buy 88% Buy 48% Buy
VIA Viacom Inc Class A 79.34 -0.44 100% Buy 100% Buy 40% Buy 64% Buy
OPLK Oplink Communications 21.41 +0.79 100% Buy 100% Buy 96% Buy 100% Buy
MAKO Mako Surgical 15.40 -0.22 100% Buy 100% Buy 72% Buy 64% Buy
FANG Diamondback Energy Inc. 43.10 +0.45 100% Buy 100% Buy 56% Buy 80% Buy
ACAT Arctic Cat Inc. 57.97 +1.08 100% Buy 100% Buy 100% Buy 100% Buy
UBNK United Financial Bancorp 16.50 +0.84 100% Buy 16% Buy 48% Buy 80% Buy
PWX Providence And Worcester 18.40 +0.38 100% Buy 100% Buy 88% Buy 56% Sell
SREV Servicesource Internationa 12.82 +0.15 100% Buy 100% Buy 64% Buy 100% Buy
VIAS Viasystems Group 18.30 +3.53 88% Buy 40% Buy 48% Buy 80% Sell
JACK Jack In The Box Inc. 42.30 +1.50 100% Buy 88% Buy 16% Buy 100% Buy
PXD Pioneer Natural Resources 180.08 -1.13 100% Buy 100% Buy 56% Buy 88% Buy
BDBD Boulder Brands Inc 16.44 -0.04 100% Buy 100% Buy 40% Buy 100% Buy
STXS Stereotaxis 9.49 +2.15 100% Buy 100% Buy 32% Buy 88% Sell
FNGN Financial Engines 53.32 +1.61 100% Buy 100% Buy 24% Buy 100% Buy
ITT Itt Industries 34.56 +0.15 100% Buy 100% Buy 16% Buy 88% Buy
CHK Chesapeake Energy Corp. 25.48 +0.53 100% Buy 100% Buy 96% Buy 64% Buy
VIAB Viacom Inc Cl B 78.75 -0.42 100% Buy 100% Buy 56% Buy 64% Buy
HY Hyster-Yale Materials Hand 77.42 -1.00 100% Buy 100% Buy 32% Buy 24% Buy
PACB Pacific Biosciences Of Cal 3.33 +0.48 100% Buy 100% Buy 16% Buy 32% Buy
PFPT Proofpoint Inc. 28.90 +0.90 100% Buy 100% Buy 100% Buy 96% Buy
MSCI MSCI Inc 37.78 +0.33 100% Buy 100% Buy 56% Buy 48% Buy
CSOD Cornerstone Ondemand Inc. 48.41 +2.29 100% Buy 96% Buy 16% Buy 64% Buy
CW Curtiss-Wright Corp. 43.96 -0.34 100% Buy 100% Buy 72% Buy 96% Buy
PULS Pulse Electronics Corp. 6.05 +1.44 88% Buy 80% Buy 48% Buy 88% Sell
TROV Trovagene Inc 9.84 -0.18 100% Buy 100% Buy 96% Buy 96% Buy
TJX Tjx Companies 54.25 +0.32 100% Buy 100% Buy 40% Buy 48% Buy
LPI Laredo Petroleum Holdings 24.59 +0.27 100% Buy 100% Buy 8% Buy 56% Buy
EGOV Nic Inc. 23.81 +0.98 88% Buy 88% Buy 16% Buy 48% Buy
VOC Voc Energy Trust 15.40 +0.68 100% Buy 96% Buy 88% Buy 64% Buy
GPI Group 1 Automotive 76.15 -0.58 100% Buy 100% Buy 100% Buy 88% Buy
ALU Alcatel Lucent 2.63 +0.11 100% Buy 96% Buy 96% Buy 24% Buy
BOFI Bofi Holding 57.99 +0.96 100% Buy 100% Buy 96% Buy 56% Buy
VRNG Vringo 3.62 +0.08 100% Buy 100% Buy 96% Buy 56% Buy
YOKU Youku.Com Inc. 25.27 +0.25 100% Buy 100% Buy 80% Buy 24% Sell
SEE Sealed Air Corp. 30.16 -0.20 100% Buy 100% Buy 56% Buy 100% Buy
JOUT Johnson Outdoors Inc. 26.85 +0.05 100% Buy 100% Buy 96% Buy 72% Buy
AGCO Agco Corp. 58.54 +0.85 100% Buy 100% Buy 32% Buy 64% Sell
RENN Renren Inc. 4.00 +0.22 100% Buy 100% Buy 72% Buy 24% Sell
CMLS Cumulus Media Inc. 4.64 +0.19 100% Buy 100% Buy 56% Buy 64% Buy
GDOT Green Dot Corp. 23.90 +0.31 100% Buy 100% Buy 96% Buy 80% Buy
MOD Modine Manufacturing Compa 13.57 -0.25 100% Buy 100% Buy 8% Sell 100% Buy
TST Thestreet.Com 2.17 +0.03 100% Buy 100% Buy 88% Buy 64% Sell
FLT Fleetcor Technologies 98.78 +0.34 100% Buy 100% Buy 96% Buy 16% Buy
GLRE Greenlight Capital Re 27.36 +0.34 100% Buy 96% Buy 40% Buy 96% Buy
ADS Alliance Data Systems Corp 205.04 +1.93 100% Buy 100% Buy 96% Buy 64% Buy
STML Stemline Therapeutics Inc. 33.09 +1.98 100% Buy 100% Buy 8% Buy 72% Buy
CNQR Concur Technologies 101.40 +1.01 100% Buy 100% Buy 56% Buy 80% Buy
CSTE Caesarstone Sdot-Yam Ltd. 35.56 +1.28 96% Buy 96% Buy 88% Buy 48% Buy
SMG Scotts Miracle-Gro Company 52.48 +0.83 100% Buy 100% Buy 56% Buy 80% Buy
BWLD Buffalo Wild Wings 108.25 +1.11 96% Buy 96% Buy 8% Buy 100% Buy
MASI Masimo Corp. 25.07 +0.39 100% Buy 100% Buy 40% Buy 56% Buy
EXAM Examworks Group 24.75 +0.55 100% Buy 100% Buy 8% Buy 96% Buy
CRL Charles River Laboratories 47.67 +1.64 88% Buy 88% Buy 72% Buy 16% Sell
ATU Actuant Corp. 36.76 -0.08 100% Buy 100% Buy 16% Buy 100% Buy
ARWR Arrowhead Research Corp. 4.21 +0.08 100% Buy 100% Buy 100% Buy 32% Sell
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading